College Park, GA · Founded 2020 · Privately Held (backing)
Developer of antiviral medicines designed for the treatment of respiratory infections and global viral threats. Altesa BioSciences is based in College Park, GA and was founded in 2020. It was valued at $190 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $114 million across 2 recorded rounds; the latest was a $75 million later-stage round in Feb 2026.
PMV mark · valuation
$190.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$114.0M
Last round
Later Stage VC
Feb 2026
Cap table — not yet on record
Altesa BioSciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Altesa BioSciences with a free account
·Watch Altesa BioSciences: the Monday email on marks, rounds and moves
Where does Altesa BioSciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Altesa BioSciences's 2 recorded funding rounds.
